| ▲ | rayiner a day ago | |||||||||||||||||||||||||||||||
The article has a bunch of speculation that’s not in the paper: https://www.nber.org/system/files/working_papers/w35387/w353... One key point: > Nor do I find evidence of upward job mobility among incumbent workers. Already-employed women do not increase hours, income per household member, or job-to-job moves. If anything, employer changes decline, possibly due to a desire to retain access to health insurance that covers these drugs. These null effects help distinguish a new-match channel from a general productivity or well-being channel This complicates the idea that it’s just people treating lighter people better. It could well be that a lot of people who take GLP-1s are obese enough where it affects their ability to go out in the world and do stuff, and losing the weight enables people to work. | ||||||||||||||||||||||||||||||||
| ▲ | WarmWash a day ago | parent | next [-] | |||||||||||||||||||||||||||||||
I also snag on her not attributing it to any personality changes because people reported no change in life satisfaction, loneliness, or depression from taking GLP-1s. Which seems to run counter to the reasons why [overweight] people would take GLP-1s I'm not about to dive into the literature, but I kinda just assumed that losing weight naturally would help all those things. | ||||||||||||||||||||||||||||||||
| ▲ | stephbook a day ago | parent | prev [-] | |||||||||||||||||||||||||||||||
The study also paints this as "kind of unfair against women", but didn't include men at all. | ||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||